ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,236, issued on Dec. 9, was assigned to NEW PORTAL Ltd. (Hong Kong).
"Genetically engineered live bacteria and methods of constructing the same" was invented by Ye Jin (Hong Kong).
According to the abstract* released by the U.S. Patent & Trademark Office: "A genetically engineered live bacterium comprising at least one effector gene that encodes a medical effector and at least one gene modification that shortens the bacterium's lifespan. After being administered to a subject, the bacterium survives within a time sufficient to allow the medical effector to exert at least one medical action and dies within a time sufficient to minimize pathogenesis to the subject. The bacterium provi...